Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.
The current price of PBBIF is $24 USD — it has increased by +0% in the past 24 hours. Watch Probi AB stock price performance more closely on the chart.
What is Probi AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Probi AB stocks are traded under the ticker PBBIF.
Is Probi AB stock price growing?▼
PBBIF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Probi AB has showed a +0% increase.
What is Probi AB revenue for the last year?▼
Probi AB revenue for the last year amounts to 59.69M USD.
What is Probi AB net income for the last year?▼
PBBIF net income for the last year is 1.61M USD.
Does Probi AB pay dividends?▼
Yes, PBBIF dividends are paid annual. The last dividend per share was 0.12 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Probi AB have?▼
As of April 03, 2026, the company has 157 employees.